Treatment With Platelet Lysate Inhibits Proteases of Synovial Fluid in Equines With Osteoarthritis.

The study investigates how platelet lysate, an anti-inflammatory treatment method, affects synovial fluid’s proteolytic enzymes in horses with osteoarthritis. The authors conclude that platelet lysate can decrease the activities of harmful enzymes and stimulate beneficial substance concentration.

Objective and Background of the Study

• This study aims to understand how platelet lysate (PL), an anti-inflammatory treatment typically used for musculoskeletal conditions, affects the proteolytic enzymes – enzymes that break down proteins – in synovial fluid from horses with osteoarthritis (OA).
• OA is a prevalent arthropathy (joint disease) among sport horses. The research intends to help find more effective treatment methods.

Methods

• The researchers began treatment by administering 1 mL of platelet lysate (PL) into the affected horses’ joints. They then extracted and analyzed synovial fluid from these horses on days 0, 10, 30, and 60 post-treatment.
• The team focused their molecular analysis on the levels of multiple substances. These included two types of matrix metalloproteinases (MMP-2 and MMP-9), which help break down the extracellular matrix in normal physiological processes, such as embryogenesis and tissue remodeling, but can contribute to diseases like OA when unbalanced.
• The authors also studied a disintegrin and metalloproteinase with thrombospondin motifs 5 (ADAMTS-5), an enzyme associated with the degradation of cartilage, as well as glycosaminoglycans (GAGs), proteins that facilitate cell signalling, and tissue inhibitor of metalloproteinase 1 (TIMP-1), a protein that regulates cell activation and immune response.

Results

• The team found a significant decrease in MMP-9 levels on day 10 post-treatment, indicating that the PL was effective in inhibiting the proteolytic enzyme’s activity.
• ADAMTS-5 also decreased significantly on days 10, 30, and 60 post-treatment, suggesting a reduced rate of cartilage degradation.
• Synovial TIMP-1 levels increased significantly on day 30 post-treatment. This increase might represent an enhanced regulation of cell activation and immune response due to the PL treatment.
• Glycosaminoglycans (GAGs) showed a significant increase on days 10 and 30, which could lead to improved cell signalling in affected areas.
• Additionally, MMP-2 levels decreased significantly on days 10, 30, and 60 post-treatment, showing further beneficial effects of the PL treatment.

Conclusion

• This research concludes that the administration of platelet lysate can inhibit the harmful activities of MMP-2, MMP-9, and ADAMTS-5, making this a potentially effective treatment for horses with osteoarthritis.
• Aside from suppressing harmful enzymes, the PL promotes the concentration of GAGs and TIMP-1, which can support cell signalling and immune response regulation.